Porous ABPBI [phosphoric acid doped poly (2, 5-benzimidazole)] membrane and process of preparing the same

US9757696B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9757696-B2
Application numberUS-201414223508-A
CountryUS
Kind codeB2
Filing dateMar 24, 2014
Priority dateFeb 26, 2010
Publication dateSep 12, 2017
Grant dateSep 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a porous ABPBI (phosphoric acid doped poly (2, 5-benzimidazole)) membrane and process of preparing the same. A stable porous ABPBI (Phosphoric Acid Doped Poly (2, 5-benzimidazole)) membrane stable to acids, bases, solvents and autoclaving is disclosed. The membrane finds use for separation of solutes in solution in acids, bases and solvents.

First claim

Opening claim text (preview).

We claim: 1. A membrane comprising: ABPBI in the form of a membrane and defining pores therethrough; wherein the membrane is stable to acids, bases, organic solvents and autoclaving. 2. The membrane of claim 1 , wherein the pores in the ABPBI membrane provide water flux of 2 to 30 l·m −2 ·h −1 at 2 bar. 3. The membrane of claim 1 , wherein said membrane is stable in concentrated inorganic acids. 4. The membrane of claim 1 , wherein said membrane is stable in concentrated base solutions. 5. The membrane of claim 3 , wherein the concentrated acid is 25 N sulfuric acid. 6. The membrane as claimed in claim 1 , wherein the membrane is configured to be used for separations of solute from solvents selected from acids, bases, organic solvents, or mixtures thereof. 7. The membrane of claim 1 , wherein said membrane is stable to organic solvents selected from the group consisting of protic polar solvents, aprotic polar solvents, and non-polar solvents.

Assignees

Inventors

Classifications

  • characterised by the presence of specified groups, e.g. introduced by chemical after-treatment · CPC title

  • B01D71/62Primary

    Polycondensates having nitrogen-containing heterocyclic rings in the main chain · CPC title

  • Specific permeability or cut-off range · CPC title

  • Chemical resistance · CPC title

  • by phase separation, sol-gel transition, evaporation or solvent quenching · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9757696B2 cover?
The present invention relates to a porous ABPBI (phosphoric acid doped poly (2, 5-benzimidazole)) membrane and process of preparing the same. A stable porous ABPBI (Phosphoric Acid Doped Poly (2, 5-benzimidazole)) membrane stable to acids, bases, solvents and autoclaving is disclosed. The membrane finds use for separation of solutes in solution in acids, bases and solvents.
Who is the assignee on this patent?
Council Scient Ind Res, Council Of Scient And Ind Res (Csir)
What technology area does this patent fall under?
Primary CPC classification B01D71/62. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).